130 likes | 160 Views
BioPad™ aims to lead in pre-natal care with innovative, non-radiating fetal activity detectors for home use, promoting a better pregnancy experience. Our products offer monitoring, reassurance, bonding, and connecting opportunities for expectant mothers.
E N D
January 2008 May 2008
Mission Statement BioPad™’s mission is to become a world leader in the field of pre-natal care by making consumer-based medical devices that improve the pregnancy experience for women and their families. The fetus care
BioPad makes home-use fetal activity detectors and dataloggers Products are passiveand non-radiating Small, convenient, elegant and hygienic Can be used anywhere, anytime. Introducing Biopad’s Fetal Monitors The fetus care
Why Fetal Movements ? • Scientific evidence suggests fetal activity is a clear indicator of wellbeing • A common medical practice is a daily manual fetal kick count by the mother (‘count to 10’) • Kick count is directly linked to lower stillbirth rates (20%-30%) • Research also shows that kick counting improves the pregnancyexperience The fetus care
Common Poster at Doctors’ Offices The fetus care
Customer Needs • Monitoring • Reassurance • Procedure • Discerning • Bonding • Dialog • Connecting The fetus care
The Products – Kicker Ticker 2 • Medical device that requires FDA approval • Consists of device (for single pregnancy) and disposable pad (one for each test) • Provides automatic and accurate monitoring • Counts and stores fetal movements (trends) • Shows real-time results • Sounds & light indications • Data output (via USB) to be shared with doctor • Each session lasts 20 minutes and can take place anywhere The fetus care
Prototype Testing Completed Successfully! The fetus care The fetus care
The Products – Kicker Ticker 1 • Non-medical, pregnancy experience focused • Intended to share movements with family members and friends • The Companion Egg™ responds to movements with tactile and light elements, creating tangible “event” • Does not require FDA approval • Fast time to market Movements Light Sounds The fetus care
The Market is Significant The fetus care
Substantial Sales Potential • KT2 costs to woman - $120 • KT1 costs to woman- $80 • Family set - $150 (Includes sensor & 3 Companion Eggs™) • Potential of +$100 million in income in year 5 of operations
$2 - $3 million second round financing Strategic partnerships: Manufacturing Distribution Marketing Company Needs The fetus care
Hanoch Kaftzan BioPad CEO T: 972.3.6093085 M: 972.52.6299629 F:972.3.6093089 Ayalon House, 16th floor 12 Abba Hillel St. Ramat Gan PO Box 25290, Tel Aviv 61251